# Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome

> **NCT04789135** · PHASE2 · UNKNOWN · sponsor: **Anhembi Morumbi University** · enrollment: 50 (actual)

## Conditions studied

- Interstitial Cystitis, Chronic
- Bladder Pain Syndrome

## Interventions

- **DRUG:** Ozone

## Key facts

- **NCT ID:** NCT04789135
- **Lead sponsor:** Anhembi Morumbi University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-20
- **Primary completion:** 2020-09-30
- **Final completion:** 2021-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04789135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04789135, "Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04789135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*